logo
virologik-01
linkes_image_bild
  • Deutsch
  • Welcome
  • About ViroLogik
  • R & D
  • News
  • Welcome
    • Startseite
      • Welcome
  • About ViroLogik
    • Portrait
    • Management
    • Milestones
    • Supervisory Board
      • Scientific Advisory Board
      • Supervisory Board
    • Investors
      • Investors
      • MIG AG
      • S-Refit AG
      • medTECH
      • kfw Bank
    • Cooperations
      • Scientific and medical partnerships
      • Cooperation Partners
    • Location
    • Jobs & Career
      • Jobs at ViroLogik
  • R & D
    • ViroLogik´s innovative approach
    • Clinical proof of concept
    • Pipeline
    • Indication HCV
      • Medical significance
      • Replication cycle and pathogenesis
      • Therapeutic approaches
    • Indication HIV
      • Medical significance
      • Replication cycle
      • Therapeutic approaches
        • Therapeutic approaches
    • Indication IAV
      • Medical significance
      • Replication cycle
  • News
    • Press
      • 17.05.2010
      • 01.05.2010
      • 10.12.2008
      • 28.05.2008
      • 08.05.2008
    • Publications
      • 2010
        • 2010
      • 2009
        • 2009
      • 2008
        • 2008
      • 2007
        • 2007
      • 2005
        • 2005
      • 2003
        • 2003
      • 2000-2002
        • 2000
    • 17.05.2010
    • 01.05.2010
    • 10.12.2008
    • 28.05.2008
    • 08.05.2008
  • Contact
  • Sitemap
  • Imprint
  • Contact
  • Sitemap
  • Imprint

Presse

  • 17.05.2010
  • 01.05.2010
  • 10.12.2008
  • 28.05.2008

Publications

  • 2010
  • 2009
  • 2008
  • 2007

Contact
ViroLogik GmbH
Henkestraße 91
D-91052 Erlangen

Fon: +49 9131 /  97 44 34 -0
Fax: +49 9131 /  97 44 34 -43

E-Mail: info@virologik.com